Purchase Order 75N95D20P00075

<p>The National Institute on Aging awarded a purchase order to Novogene Corporation Inc. for $19,370.00 on March 2, 2021, for human mRNA sequencing services. The order, a firm fixed-price acquisition with no set-aside, is scheduled for completion by June 4, 2021. Work is performed in Chula Vista, California. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services.</p>

This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian federal agency, to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for $21,800 and covers laboratory and testing services, specifically strand-specific mRNA sequencing and bioinformatics analysis, with a period of performance through March 31, 2026. Novogene has an established track record of providing advanced genomic sequencing...

<p>The National Cancer Institute awarded a purchase order to Novogene Corporation Inc. for $24,750.00 in testing services on July 27, 2020, with completion targeted for February 22, 2021. Work is performed in Chula Vista, California. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services. The order is firm fixed price with no set-aside category applied.</p>

<p>The National Cancer Institute awarded a purchase order to Novogene Corporation Inc. for $11,045.65 on August 7, 2020 for laboratory testing services. The order is firm fixed price with no set-aside category. Work is performed in Chula Vista, California, with an ultimate completion date of September 30, 2020. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services.</p>

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $11,820 firm fixed-price purchase order to Novogene Corporation Inc., a Sacramento, California-based minority-owned small business specializing in genomic sequencing and bioinformatics services. Awarded on September 9, 2021, with an ultimate completion date of September 28, 2022, this contract involved no small business set-aside. The award was issued to administratively de-obligate unexpended and expiring fiscal year...

<p>The National Institute of Nursing Research awarded a purchase order to Novogene Corporation Inc. for $24,700 on March 31, 2020, with completion by April 30, 2020. Work is performed in Chula Vista, California. Novogene is a minority-owned small business. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for $17,010.00 on December 1, 2020, for mRNA sequencing services. Novogene is a minority-owned small business. Work is performed in Sacramento, California. The order is firm fixed price with an ultimate completion date of February 1, 2021.</p>

This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Novogene Corporation Inc. for $13,982.00 on August 23, 2019, for RNA sequencing services. Performance is located in Bethesda, Maryland, with completion by February 28, 2020. The order is firm fixed price with no set-aside designation. Novogene is a minority-owned small business providing genomic sequencing and bioinformatics analysis.</p>

<p>The National Institute on Aging awarded a purchase order to Psomagen Inc. on August 20, 2024, for whole genome sequencing services with a ceiling value of $7,499,725 and an ultimate completion date of September 24, 2025. The order carries a Total Small Business set-aside designation. Work is performed in Rockville, Maryland. The purchase order covers whole genome sequencing on 500 samples supporting neurodegenerative disease research, procured on a firm fixed-price basis.</p>